checkAd
    Processa Pharmaceuticals Aktie
    1,4800
     
    USD
    -3,90 %
    -0,0600 USD
    Letzter Kurs 01.06.24 NYSE
    1,4500
     
    USD
    100 STK
    Geldkurs 31.05.24
    1,5300
     
    USD
    100 STK
    Briefkurs 31.05.24
    ISIN: US74275C3043 · WKN: A40161 · SYM: PCSA · USA

    Neueste Nachrichten

    Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
    26.01.24 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer
    19.01.24 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split
    18.01.24 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals to Present at the Biotech Showcase 2024
    02.01.24 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine
    19.12.23 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals to Present at the MedInvest Oncology Investor Conference
    30.11.23 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook
    29.11.23 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil Thompson
    13.11.23 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas
    09.11.23 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders
    01.11.23 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals to Present at the ThinkEquity Conference
    13.10.23 · globenewswire · Processa Pharmaceuticals
    Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    06.09.23 · globenewswire · Processa Pharmaceuticals